Assessment of nucleic acid testing (NAT) for screening hepatitis B in blood donors. Systematic review;Evaluación de las técnicas de amplificación genómica (NAT) para el tamizaje de hepatitis B en donantes de sangre. Revisión sistemática

Investigacion Clinica

Volumn 51, Issue 3, 2010, Pages 341-349

  Ruiz Aragón, Jesús ^a   Márquez Peláez, Sergio ^a  

^a JUNTA DE ANDALUCÍA   (Spain)

Author keywords

Hepatitis B; Nucleotic acid testing; Screening

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN; NUCLEIC ACID;

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; COCHRANE LIBRARY; EMBASE; HEPATITIS B; HUMAN; INFECTION RISK; MEDLINE; NUCLEIC ACID AMPLIFICATION; NUCLEIC ACID TESTING; PATIENT SAFETY; POLYMERASE CHAIN REACTION; SCREENING TEST; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

BLOOD DONORS; DNA, VIRAL; DONOR SELECTION; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES;

EID: 78650499400     PISSN: 05355133     EISSN: 05355133     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Manzini P, Girotto M, Borsotti R, Giachino O, Guaschino R, Lanteri M, Testa D, Ghiazza P, Vacchini M, Danielle F, Pizzi A, Valpreda C, Castagno F, Curti F, Magistroni P, Abate ML, Smedile A, Rizzetto M. Italian blood donors with anti-HBc and occult hepatitis B virus infection. Haematologica 2007; 92:1664-1670.
2. Loureiro CL, Alonso R, Pacheco BA, Uzcátegui MG, Villegas L, León G, De Saéz A, Liprandi F, López JL, Pujol FH. High Prevalence of GB Virus C/Hepatitis G Virus Genotype 3 among autochthonous venezuelan populations. J Med Virol 2002; 68:357-362.
3. Monsalve-Castillo F, Echevarría JM, Atencio R, Suárez A, Estévez J, Costa-León L, Montiel P, Molero T, Zambrano M. Alta prevalencia de la infección por el virus de hepatitis B en la comunidad indígena Japreira, estado Zulia, Venezuela. Cad Saúde Pública 2008; 24: 1183-1186.
4. Kuhns C, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Transfusion 2004; 44:1332-1339. (Pubitemid 39129246)
5. Datta S, Banerjee A, Chandra PK, Chakraborty S, Basu SK, Chakravarty R. Detection of a premature stop codon in the surface gene of hepatitis B virus from an HBsAg and antiHBc negative blood donor. J Clin Virol 2007; 40:255-258. (Pubitemid 47552920)
6. Gutiérrez C, León G, Loureiro CL, Uzcátegui N, Liprandi F, Pujol FH. Hepatitis B Virus DNA in blood samples positive for antibodies to core antigen and negative for surface antigen. Clin Diagn Lab Immunol 1999; 5:768-770. (Pubitemid 29441190)
7. Gutiérrez C, Devesa M, Loureiro CL, León G, Liprandi F, Pujol FH. Molecular and serological evaluation of surface antigen negative Hepatitis B virus infection in blood donors from Venezuela. J Med Virol 2004; 73:200-207. (Pubitemid 38542673)
8. Hourfar MK, Jork C, Schottstedt V, Weber-Schehl M, Brixner V, Busch MP, Geusendam G, Gubbe K, Mahnhardt C, Mayr-Wohlfart U, Pichl L, Roth WK, Schmidt M, Seifried E, Wright DJ, German Red Cross NAT Study Group. Experience of german red cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus- 1, hepatitis C virus and hepatitis B virus. Transfusion 2008; 48:1558-1566.
9. Satake M, Taira R, Yugi H, Hino S, Kanemitsu K, Ikeda H, Tadokoro K. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Transfusion 2007; 47:1197-1205. (Pubitemid 46934327)
10. Margaritis AR, Brown SM, Seed CR, Kiely P, D'Agostino B, Séller AJ. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA. Transfusion 2007; 47:1783-1793. (Pubitemid 47438540)
11. Katsoulidou A, Moschidis Z, Sypsa V, Chini M, Papatheodoridis GV, Tassopoulos N. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load. Vox Sang 2007; 92:8-14. (Pubitemid 44950344)
12. Japanese Red Cross Society. Activities of Japanese Red Cross Blood Programme 2008. Disponible en: http://www. jrc.or.jp /english/activity/blood. html.
13. Whiting PF, Westwood ME, Rutjes AWS, Reitsma JB, Bossuyt PNM, Kleijnen J. Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies. BMC Med Res Methodol 2006; 6:9-16.
14. Roth WK, Weber M, Petersen D, Drosten C, Buhr S, Sireis W, Weichert W, Hedges D, Seifried E. NAT for HBV and anti-HBc testing increase blood safety. Transfusion 2002; 42:869-875.
15. Chevrier MC, St-Louis M, Perreault J, Caron B, Castilloux C, Laroche J, Delage G. Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen- reactive blood donors in Québec with an in-house nucleic acid testing assay. Transfusion 2007; 47:1794-1802. (Pubitemid 47438544)
16. Chiquete E, Sánchez LV, Becerra G, Quintero A, Maldonado M, Panduro A. Performance of the serologic and molecular screening of blood donations for the hepatitis B and C viruses in a Mexican Transfusion Center. Ann Hepatol 2005; 4: 275-278.
17. Makroo RN, Choudhury N, Jagannathan L, Parihar-Malhotra M, Raina V, Chaudhary RK, Marwaha N, Bhatia NK, Ganguly AK. Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus-1 and hepatitis B&C viruses in Indian blood donors. Indian J Med Res 2008; 127:140-147. (Pubitemid 351936164)
18. Nantachit N, Thaikruea L, Thongsawat S, Leetrakool N, Fongsatikul L, Sompan P, Fong YL, Nichols D, Ziermann R, Ness P, Nelson KE. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand. Transfusion 2007; 47:1803-1808. (Pubitemid 47438545)
19. Mine H, Emura H, Miyamoto M, Tomono T, Minegishi K, Murokawa H, Yamanaka R, Yoshikawa A, Nishioka K; Japanese Red Cross NAT Research Group. High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan. J Virol Methods 2003; 112:145-151. (Pubitemid 37338268)
20. Minegishi K, Yoshikawa A, Kishimoto S, Yugi H, Yokoya N, Sakurada M, Kiyokawa H, Nishioka K; Japanese Red Cross NAT Screening Research Group. Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening. Vox Sang 2003; 84:287-291.
21. Ohnuma H, Tanaka T, Yoshikawa A, Murokawa H, Minegishi K, Yamanaka R, Lizuka HY, Miyamoto M, Satoh S, Nakahira S, Tomono T, Murozuka T, Takeda Y, Doi Y, Mine H, Yokoyama S, Hirose T, Nishioka K. Japanese Red Cross NAT Screening Research Group. The first large-scale nucleic acid amplification testing (NAT) of donated blood using multiplex reagent for simultaneous detection of HBV, HCV, and HIV-1 and significance of NAT for HBV. Microbiol Inmunol 2001; 45:667-672.
22. Bush MP. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?. Transfusion 2004; 11:26-32.
23. Kuhns MC, Busch MP. New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods. Mol Diagn Ther 2006; 10:77-91.
24. Marshall DA, Kleinman SH, Wong JB, AuBuchon JP, Grima DT, Kulin NA, Weinstein MC. Cost-effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States. Vox Sang 2004; 86:28-40.